| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GB:0QW0
arGEN X
|
May 08, 2026 | BUY |
Strong Buy
-23.0% avg upside
24 analysts
|
— | · |
|
GB:0QIU
Novo Nordisk
|
May 07, 2026 | HOLD |
Hold
+40.1% avg upside
28 analysts
|
— | · |
|
PFE
Pfizer
|
May 06, 2026 | BUY |
Buy
+34.7% avg upside
45 analysts
|
— | -3.9% |
|
GB:GSK
GlaxoSmithKline
|
Apr 29, 2026 | HOLD |
Hold
-2.6% avg upside
25 analysts
|
— | · |
|
GB:AZN
AstraZeneca
|
Apr 29, 2026 | BUY |
Strong Buy
+11.7% avg upside
26 analysts
|
$16400.00
23.47% Upside
|
· |
|
CH:NOVN
Novartis AG
|
Apr 28, 2026 | HOLD |
Buy
-10.8% avg upside
30 analysts
|
— | · |
|
CH:ROP
Roche Holding AG
|
Feb 02, 2026 | BUY |
Strong Buy
+3.5% avg upside
23 analysts
|
— | · |
|
ABBV
AbbVie
|
Nov 04, 2025 | HOLD |
Buy
-2.2% avg upside
43 analysts
|
$237.00
3.06% Upside
|
+6.7% |
|
FR:SAN
Sanofi
|
Oct 24, 2025 | BUY |
Strong Buy
+35.8% avg upside
30 analysts
|
— | · |
|
NL:PHIA
Koninklijke Philips N.V.
|
Jul 29, 2025 | HOLD |
Buy
+30.6% avg upside
20 analysts
|
— | · |
|
GILD
Gilead Sciences
|
Feb 13, 2025 | BUY |
Strong Buy
-5.3% avg upside
66 analysts
|
$108.00
13.56% Downside
|
+50.3% |
|
AMGN
Amgen
|
May 07, 2024 | BUY |
Buy
-12.8% avg upside
57 analysts
|
$343.00
0.58% Downside
|
-5.3% |
|
REGN
Regeneron
|
May 06, 2024 | BUY |
Strong Buy
+26.8% avg upside
57 analysts
|
$1065.00
73.81% Upside
|
-41.7% |
|
LLY
Eli Lilly & Co
|
May 03, 2024 | HOLD |
Buy
-10.5% avg upside
47 analysts
|
$800.00
27.50% Downside
|
+12.8% |
|
BMY
Bristol-Myers Squibb
|
Apr 30, 2024 | BUY |
Buy
+8.2% avg upside
42 analysts
|
$50.00
8.65% Downside
|
+19.9% |
|
MRK
Merck & Company
|
Apr 29, 2024 | BUY |
Strong Buy
+9.7% avg upside
43 analysts
|
$148.00
28.16% Upside
|
-33.0% |
|
JNJ
Johnson & Johnson
|
Apr 18, 2024 | BUY |
Strong Buy
-4.4% avg upside
36 analysts
|
$176.00
23.84% Downside
|
+11.5% |
|
BIIB
Biogen
|
Feb 15, 2024 | HOLD |
Buy
+23.7% avg upside
51 analysts
|
$236.00
18.22% Upside
|
-38.5% |
|
PFS
Provident Financial Services
|
Nov 02, 2023 | BUY |
Strong Buy
+33.6% avg upside
16 analysts
|
$39.00
69.42% Upside
|
+32.7% |
|
DE:SHL
Siemens Healthineers AG
|
Apr 20, 2022 | HOLD |
Buy
+50.9% avg upside
22 analysts
|
— | · |
|
GSK
GlaxoSmithKline
|
Feb 11, 2022 | HOLD |
Hold
-14.2% avg upside
19 analysts
|
— | -15.5% |
|
DE:FPE3
Fuchs Petrolub
|
Aug 24, 2021 | BUY |
Strong Buy
+22.8% avg upside
10 analysts
|
— | · |
|
MDT
Medtronic
|
May 14, 2020 | HOLD |
Buy
+23.6% avg upside
38 analysts
|
$92.00
16.06% Upside
|
+36.5% |
|
PHG
Koninklijke Philips
|
Mar 24, 2020 | BUY |
Strong Buy
+29.7% avg upside
13 analysts
|
$41.43
53.53% Upside
|
+57.4% |
|
NVO
Novo Nordisk
|
May 03, 2018 | SELL |
Hold
+158.8% avg upside
26 analysts
|
— | -1.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.